Small molecule cognitive enhancer reverses age-related memory decline in mice

  1. Karen Krukowski  Is a corresponding author
  2. Amber Nolan
  3. Elma S Frias
  4. Morgane Boone
  5. Gonzalo Ureta
  6. Katherine Grue
  7. Maria-Serena Paladini
  8. Edward Elizarraras
  9. Luz Delgado
  10. Sebastian Bernales
  11. Peter Walter  Is a corresponding author
  12. Susanna Rosi  Is a corresponding author
  1. University of California, San Francisco, United States
  2. Fundación Ciencia & Vida, Chile
  3. Howard Hughes Medical Institute, University of California, San Francisco, United States

Abstract

With increased life expectancy age-associated cognitive decline becomes a growing concern, even in the absence of recognizable neurodegenerative disease. The integrated stress response (ISR) is activated during aging and contributes to age-related brain phenotypes. We demonstrate that treatment with the drug-like small-molecule ISR inhibitor ISRIB reverses ISR activation in the brain, as indicated by decreased levels of activating transcription factor 4 (ATF4) and phosphorylated eukaryotic translation initiation factor eIF2. Furthermore, ISRIB treatment reverses spatial memory deficits and ameliorates working memory in old mice. At the cellular level in the hippocampus, ISR inhibition i) rescues intrinsic neuronal electrophysiological properties, ii) restores spine density and iii) reduces immune profiles, specifically interferon and T cell-mediated responses. Thus, pharmacological interference with the ISR emerges as a promising intervention strategy for combating age-related cognitive decline in otherwise healthy individuals.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Karen Krukowski

    Department of Physical Therapy and Rehabilitation Science, Brain and Spinal Injury Center, University of California, San Francisco, San Francisco, United States
    For correspondence
    karen.krukowski@ucsf.edu
    Competing interests
    No competing interests declared.
  2. Amber Nolan

    Brain and Spinal Injury Center, Department of Pathology,, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  3. Elma S Frias

    Brain and Spinal Injury Center, Department of Pathology,, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  4. Morgane Boone

    Biochemistry and Biophysics, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7807-5542
  5. Gonzalo Ureta

    Fundación Ciencia & Vida, Santiago, Chile
    Competing interests
    Gonzalo Ureta, Works at Fundacion Ciencia & Vida and receive partial funding from Praxis Biotech..
  6. Katherine Grue

    Department of Physical Therapy and Rehabilitation Science, Brain and Spinal Injury Center, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  7. Maria-Serena Paladini

    Department of Physical Therapy and Rehabilitation Science, Brain and Spinal Injury Center, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  8. Edward Elizarraras

    Department of Physical Therapy and Rehabilitation Science, Brain and Spinal Injury Center, University of California, San Francisco, San Francisco, United States
    Competing interests
    No competing interests declared.
  9. Luz Delgado

    Fundación Ciencia & Vida, Santiago, Chile
    Competing interests
    No competing interests declared.
  10. Sebastian Bernales

    Fundación Ciencia & Vida, Santiago, Chile
    Competing interests
    Sebastian Bernales, SB is an employee of Praxis Biotech..
  11. Peter Walter

    Department of Biochemistry and Biophysics, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, United States
    For correspondence
    peter@walterlab.ucsf.edu
    Competing interests
    Peter Walter, P.W. is an inventor on U.S. Patent 9708247 held by the Regents of the University of California that describes ISRIB and its analogs. Rights to the invention have been licensed by UCSF to Calico. P.W. is a consultant for Praxis Biotech LLC and Black Belt TX Limited..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6849-708X
  12. Susanna Rosi

    Brain and Spinal Injury Center, University of California, San Francisco, San Francisco, United States
    For correspondence
    susanna.rosi@ucsf.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9269-3638

Funding

National Institute on Aging (F32AG054126)

  • Karen Krukowski

National Institutes of Health (R01AG056770)

  • Susanna Rosi

National Center for Advancing Translational Sciences (TL1 TR001871)

  • Amber Nolan

National Institute of Neurological Disorders and Stroke (K08NS114170)

  • Amber Nolan

Howard Hughes Medical Institute

  • Peter Walter

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the University of California, San Francisco.(Protocol 170302).

Copyright

© 2020, Krukowski et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 49,090
    views
  • 4,493
    downloads
  • 101
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Karen Krukowski
  2. Amber Nolan
  3. Elma S Frias
  4. Morgane Boone
  5. Gonzalo Ureta
  6. Katherine Grue
  7. Maria-Serena Paladini
  8. Edward Elizarraras
  9. Luz Delgado
  10. Sebastian Bernales
  11. Peter Walter
  12. Susanna Rosi
(2020)
Small molecule cognitive enhancer reverses age-related memory decline in mice
eLife 9:e62048.
https://doi.org/10.7554/eLife.62048

Share this article

https://doi.org/10.7554/eLife.62048

Further reading

    1. Neuroscience
    Nishal Pradeepbhai Shah, AJ Phillips ... EJ Chichilnisky
    Tools and Resources

    Neural implants have the potential to restore lost sensory function by electrically evoking the complex naturalistic activity patterns of neural populations. However, it can be difficult to predict and control evoked neural responses to simultaneous multi-electrode stimulation due to nonlinearity of the responses. We present a solution to this problem and demonstrate its utility in the context of a bidirectional retinal implant for restoring vision. A dynamically optimized stimulation approach encodes incoming visual stimuli into a rapid, greedily chosen, temporally dithered and spatially multiplexed sequence of simple stimulation patterns. Stimuli are selected to optimize the reconstruction of the visual stimulus from the evoked responses. Temporal dithering exploits the slow time scales of downstream neural processing, and spatial multiplexing exploits the independence of responses generated by distant electrodes. The approach was evaluated using an experimental laboratory prototype of a retinal implant: large-scale, high-resolution multi-electrode stimulation and recording of macaque and rat retinal ganglion cells ex vivo. The dynamically optimized stimulation approach substantially enhanced performance compared to existing approaches based on static mapping between visual stimulus intensity and current amplitude. The modular framework enabled parallel extensions to naturalistic viewing conditions, incorporation of perceptual similarity measures, and efficient implementation for an implantable device. A direct closed-loop test of the approach supported its potential use in vision restoration.

    1. Neuroscience
    Cuong Pham, Yuji Komaki ... Dongdong Li
    Research Article

    Brain water homeostasis not only provides a physical protection, but also determines the diffusion of chemical molecules key for information processing and metabolic stability. As a major type of glia in brain parenchyma, astrocytes are the dominant cell type expressing aquaporin water channel. How astrocyte aquaporin contributes to brain water homeostasis in basal physiology remains to be understood. We report that astrocyte aquaporin 4 (AQP4) mediates a tonic water efflux in basal conditions. Acute inhibition of astrocyte AQP4 leads to intracellular water accumulation as optically resolved by fluorescence-translated imaging in acute brain slices, and in vivo by fiber photometry in mobile mice. We then show that aquaporin-mediated constant water efflux maintains astrocyte volume and osmotic equilibrium, astrocyte and neuron Ca2+ signaling, and extracellular space remodeling during optogenetically induced cortical spreading depression. Using diffusion-weighted magnetic resonance imaging (DW-MRI), we observed that in vivo inhibition of AQP4 water efflux heterogeneously disturbs brain water homeostasis in a region-dependent manner. Our data suggest that astrocyte aquaporin, though bidirectional in nature, mediates a tonic water outflow to sustain cellular and environmental equilibrium in brain parenchyma.